Diffuse Astrocytoma, IDH-Wildtype
2 clinical trials · Condition
◉ Watch Diffuse Astrocytoma, IDH-Wildtype
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma (NCT04729959) | National Cancer Institute (NCI) | 2022-03-11 |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931) | M.D. Anderson Cancer Center | 2020-01-30 |
Track Diffuse Astrocytoma, IDH-Wildtype automatically
Every clearance here is in the API, with alerts when new ones post.